Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (27781)	4/29/1998 10:05:00 AM
From: tom r. phillips	Read Replies (1) \| Respond to of 132070

Michael -- re. drug co. puts: how far out in time? "nearly any name in the group is overpriced enough to be worth a third of puts". tom phillips

To: Knighty Tin who wrote (27781)	4/29/1998 4:36:00 PM
From: KENNETH R SANDERS	Read Replies (2) \| Respond to of 132070

MB>>>>>PFE, as opposed to many of the drug cos., is a good firm. They have a handle on growing into the next decade. However, 67 times eps is just downright silly. I still prefer Warner-Lambert as my bear play, but nearly any name in the group is overpriced enough to be worth a third of puts. MB<<<<<<<<<<<<<<<<<< Been in PFE for a month and WLA for 2 wks. UP 27M on PFE- UP 14.5M on WLA. and you are right, it is "upright silly". Must be the" VIAGARA"effect. Got my finger on the trigger to avoid the" NIAGARA" effect<G>